Nifty
Sensex
:
:
10763.40
35774.88
81.20 (0.76%)
317.72 (0.90%)

Pharmaceuticals & Drugs

Rating :
55/99

BSE: 524824 | NSE: BALPHARMA

80.40
-1.55 (-1.89%)
19-Nov-2018 | 3:56PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  82.25
  •  82.25
  •  80.10
  •  81.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  13857
  •  11.14
  •  128.20
  •  69.35

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 116.85
  • 16.20
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 222.66
  • 1.21%
  • 1.57

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 42.45%
  • 1.38%
  • 37.17%
  • FII
  • DII
  • Others
  • 0.2%
  • 0.00%
  • 18.80%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.20
  • 3.03
  • 1.66

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.05
  • 4.96
  • 5.84

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.07
  • 3.22
  • 28.34

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.29
  • 25.70
  • 31.58

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.34
  • 1.77
  • 2.08

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.27
  • 8.11
  • 9.26

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Dec 17
Dec 16
Var%
Sep 17
Sep 16
Var%
Net Sales
0.00
0.00
0.00
58.91
64.35
-8.45%
52.04
58.65
-11.27%
0.00
66.25
-100.00%
Expenses
0.00
0.00
0.00
53.16
61.28
-13.25%
47.31
55.04
-14.04%
0.00
62.01
-100.00%
EBITDA
0.00
0.00
0.00
5.75
3.06
87.91%
4.73
3.60
31.39%
0.00
4.24
-100.00%
EBIDTM
0.00%
0.00%
9.76%
4.76%
9.09%
6.15%
0.00%
6.40%
Other Income
0.00
0.00
0.00
-0.24
0.93
-
0.08
0.03
166.67%
0.00
1.38
-100.00%
Interest
0.00
0.00
0.00
2.67
2.33
14.59%
2.32
2.03
14.29%
0.00
2.19
-100.00%
Depreciation
0.00
0.00
0.00
1.98
2.25
-12.00%
1.58
1.33
18.80%
0.00
1.41
-100.00%
PBT
0.00
0.00
0.00
0.87
-0.58
-
0.91
0.28
225.00%
0.00
2.00
-100.00%
Tax
0.00
0.00
0.00
1.21
1.24
-2.42%
0.44
0.53
-16.98%
0.00
1.13
-100.00%
PAT
0.00
0.00
0.00
-0.34
-1.83
-
0.47
-0.25
-
0.00
0.87
-100.00%
PATM
0.00%
0.00%
-0.58%
-2.84%
0.91%
-0.43%
0.00%
1.31%
EPS
0.00
0.00
0.00
-0.24
-1.29
-
0.33
0.43
-23.26%
0.00
1.23
-100.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Net Sales
-
209.29
228.91
198.32
187.16
178.87
114.29
106.23
103.60
85.74
70.81
Net Sales Growth
-
-8.57%
15.42%
5.96%
4.63%
56.51%
7.59%
2.54%
20.83%
21.08%
 
Cost Of Goods Sold
-
88.57
103.94
94.06
87.49
83.74
54.71
55.24
48.46
38.78
28.06
Gross Profit
-
120.71
124.97
104.25
99.67
95.14
59.58
50.99
55.14
46.96
42.75
GP Margin
-
57.68%
54.59%
52.57%
53.25%
53.19%
52.13%
48.00%
53.22%
54.77%
60.37%
Total Expenditure
-
192.09
214.10
183.46
170.05
161.00
104.36
100.95
93.07
77.28
63.03
Power & Fuel Cost
-
6.07
6.17
4.66
4.54
4.39
2.90
2.13
2.13
1.89
1.52
% Of Sales
-
2.90%
2.70%
2.35%
2.43%
2.45%
2.54%
2.01%
2.06%
2.20%
2.15%
Employee Cost
-
47.18
45.37
37.30
32.24
28.12
20.58
19.73
20.37
12.31
11.46
% Of Sales
-
22.54%
19.82%
18.81%
17.23%
15.72%
18.01%
18.57%
19.66%
14.36%
16.18%
Manufacturing Exp.
-
18.03
21.44
19.80
20.78
18.23
11.24
8.90
7.84
6.78
7.51
% Of Sales
-
8.61%
9.37%
9.98%
11.10%
10.19%
9.83%
8.38%
7.57%
7.91%
10.61%
General & Admin Exp.
-
16.49
16.82
13.98
12.43
11.54
5.41
4.71
4.42
7.80
7.24
% Of Sales
-
7.88%
7.35%
7.05%
6.64%
6.45%
4.73%
4.43%
4.27%
9.10%
10.22%
Selling & Distn. Exp.
-
15.63
19.50
13.18
11.91
13.49
8.73
9.62
8.90
7.90
5.94
% Of Sales
-
7.47%
8.52%
6.65%
6.36%
7.54%
7.64%
9.06%
8.59%
9.21%
8.39%
Miscellaneous Exp.
-
0.12
0.86
0.47
0.65
1.48
0.78
0.62
0.95
1.82
5.94
% Of Sales
-
0.06%
0.38%
0.24%
0.35%
0.83%
0.68%
0.58%
0.92%
2.12%
1.84%
EBITDA
-
17.20
14.81
14.86
17.11
17.87
9.93
5.28
10.53
8.46
7.78
EBITDA Margin
-
8.22%
6.47%
7.49%
9.14%
9.99%
8.69%
4.97%
10.16%
9.87%
10.99%
Other Income
-
1.73
3.04
1.28
1.17
0.65
0.79
2.94
0.12
0.75
0.04
Interest
-
9.27
8.49
6.48
6.52
7.16
6.79
6.26
4.71
3.37
3.23
Depreciation
-
6.77
6.49
7.01
7.02
4.74
2.90
2.86
1.89
1.63
1.42
PBT
-
2.88
2.87
2.65
4.74
6.63
1.04
-0.91
4.06
4.20
3.16
Tax
-
2.51
3.27
2.39
1.19
1.55
0.63
0.52
1.06
1.35
1.14
Tax Rate
-
87.15%
113.94%
90.19%
25.11%
23.38%
60.58%
-57.14%
26.11%
32.14%
36.08%
PAT
-
2.79
1.75
1.41
3.62
5.07
0.41
-1.43
2.99
2.86
2.02
PAT before Minority Interest
-
0.38
-0.40
0.26
3.55
5.07
0.41
-1.43
2.99
2.86
2.02
Minority Interest
-
2.41
2.15
1.15
0.07
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
1.33%
0.76%
0.71%
1.93%
2.83%
0.36%
-1.35%
2.89%
3.34%
2.85%
PAT Growth
-
59.43%
24.11%
-61.05%
-28.60%
1,136.59%
-
-
4.55%
41.58%
 
Unadjusted EPS
-
0.10
-0.52
1.09
2.83
4.77
39.00
-136.00
2.85
2.74
1.93

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Shareholder's Funds
64.99
62.45
54.90
55.20
50.05
36.18
35.76
37.23
34.80
33.40
Share Capital
14.17
14.17
12.87
12.87
11.11
10.48
10.48
10.48
10.45
10.45
Total Reserves
50.82
48.27
40.01
40.31
37.20
25.50
25.09
26.52
24.36
22.96
Non-Current Liabilities
46.41
30.02
45.12
16.34
17.92
64.54
60.66
52.96
50.31
40.02
Secured Loans
33.60
12.76
15.24
6.11
6.58
53.76
54.41
46.34
42.12
32.99
Unsecured Loans
1.43
5.04
19.71
0.53
1.39
3.97
0.01
0.83
3.19
2.40
Long Term Provisions
2.54
3.42
2.28
1.65
1.06
0.00
0.00
0.00
0.00
0.00
Current Liabilities
145.21
143.24
111.19
92.36
86.77
34.59
27.78
31.47
23.51
17.06
Trade Payables
45.26
54.43
46.85
38.53
33.53
27.02
22.07
22.62
16.74
10.26
Other Current Liabilities
29.26
16.45
12.01
11.86
8.66
6.03
4.73
6.49
3.70
4.80
Short Term Borrowings
68.31
71.07
50.09
40.14
42.75
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
2.37
1.29
2.24
1.83
1.83
1.53
0.99
2.36
3.07
1.99
Total Liabilities
251.82
233.33
211.03
163.87
154.74
135.31
124.20
121.66
108.62
90.48
Net Block
70.55
59.98
56.23
52.20
55.18
54.26
54.98
54.93
26.64
26.06
Gross Block
83.78
66.44
106.10
95.14
90.11
76.86
74.11
67.45
37.35
34.62
Accumulated Depreciation
13.23
6.46
49.87
42.95
34.93
22.60
19.13
12.53
10.71
8.56
Non Current Assets
75.87
68.78
68.03
58.74
59.63
54.40
55.00
55.34
45.94
32.94
Capital Work in Progress
0.21
1.70
3.93
0.77
0.25
0.13
0.00
0.40
19.29
6.76
Non Current Investment
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.12
Long Term Loans & Adv.
4.19
6.61
7.54
5.42
3.95
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.90
0.46
0.32
0.34
0.24
0.00
0.00
0.00
0.00
0.00
Current Assets
175.94
164.55
143.00
105.12
95.12
80.90
69.20
61.38
58.05
53.23
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
66.49
54.73
41.75
35.82
31.71
32.21
28.62
23.89
25.45
23.89
Sundry Debtors
60.18
61.80
56.94
44.98
45.49
37.02
31.92
29.29
23.34
21.73
Cash & Bank
4.15
4.71
4.63
5.49
3.02
2.23
1.61
1.49
0.73
0.86
Other Current Assets
45.11
0.86
1.21
1.35
14.89
9.44
7.05
6.73
8.53
6.76
Short Term Loans & Adv.
44.79
42.45
38.45
17.48
13.96
5.56
4.59
3.62
8.53
6.76
Net Current Assets
30.73
21.31
31.81
12.77
8.35
46.31
41.42
29.91
34.54
36.17
Total Assets
251.81
233.33
211.03
163.86
154.75
135.30
124.20
121.66
108.62
90.48

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Cash From Operating Activity
-0.50
6.31
-19.35
14.53
13.31
4.61
-5.22
12.89
9.10
7.83
PBT
2.88
2.87
2.65
4.74
6.63
1.04
-0.91
4.06
4.20
3.16
Adjustment
15.82
14.79
11.46
11.69
10.43
9.49
7.12
6.56
4.82
5.02
Changes in Working Capital
-17.94
-9.95
-32.66
-0.59
-2.59
-6.10
-10.70
3.29
0.60
0.21
Cash after chg. in Working capital
0.77
7.72
-18.55
15.84
14.47
4.43
-4.48
13.90
9.63
8.39
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-1.27
-1.40
-0.80
-1.31
-1.16
0.18
-0.74
-1.01
-0.53
-0.55
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-3.56
-7.96
-13.88
-5.30
-7.30
-1.59
4.61
-11.34
-14.37
-8.19
Net Fixed Assets
-3.80
41.86
-12.93
-5.24
-15.62
-2.86
-6.26
-11.18
-14.23
Net Investments
-6.50
1.16
-0.09
-1.07
0.04
0.00
0.03
0.00
0.06
Others
6.74
-50.98
-0.86
1.01
8.28
1.27
10.84
-0.16
-0.20
Cash from Financing Activity
3.55
-5.94
32.37
-6.80
-7.52
-2.40
0.74
-2.96
6.29
-4.22
Net Cash Inflow / Outflow
-0.51
-7.58
-0.86
2.43
-1.51
0.62
0.13
-1.41
1.02
-4.58
Opening Cash & Equivalents
-25.30
-17.72
5.49
3.02
4.53
1.61
1.49
2.90
1.91
6.48
Closing Cash & Equivalent
-25.82
-25.30
4.63
5.45
3.02
2.23
1.61
1.49
2.92
1.90

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 11
Mar 10
Mar 09
Mar 08
Mar 07
Book Value (Rs.)
45.86
44.06
41.09
41.32
43.48
34.33
33.94
30.59
28.88
27.85
ROA
0.16%
-0.18%
0.14%
2.23%
3.50%
0.31%
-1.16%
2.60%
2.87%
2.26%
ROE
0.59%
-0.69%
0.49%
7.00%
12.03%
1.14%
-4.22%
9.62%
9.64%
7.08%
ROCE
7.36%
7.59%
7.35%
10.88%
14.05%
8.51%
6.31%
11.32%
10.82%
9.88%
Fixed Asset Turnover
2.82
2.72
2.01
2.06
2.18
1.60
1.58
2.12
2.54
2.54
Receivable days
105.27
92.23
91.87
86.58
82.73
104.23
99.58
86.63
90.02
102.00
Inventory Days
104.61
74.94
69.91
64.63
64.10
91.99
85.43
81.22
98.55
113.26
Payable days
97.54
88.16
89.31
79.05
72.93
89.00
77.88
79.60
71.99
68.40
Cash Conversion Cycle
112.34
79.02
72.47
72.17
73.90
107.22
107.13
88.25
116.58
146.86
Total Debt/Equity
1.69
1.49
1.68
0.93
1.08
1.60
1.53
1.47
1.50
1.22
Interest Cover
1.31
1.34
1.41
1.73
1.93
1.15
0.86
1.86
2.25
1.98

Annual Reports:

News Update:


  • Bal Pharma - Quarterly Results
    14th Nov 2018, 16:56 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.